Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing ...

Moderna is down 35.3% since the beginning of the year, and at $27.16 per share, it is trading 50.3% below its 52-week high of ...

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.

Moderna's shares have been southbound for the past few years due to unimpressive financial results. However, progress with ...

Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

With the three healthcare stocks featured below, any "buying the dip" in them today could prove to be a regretful mistake in ...

Tesla’s stock was down 0.8% at the close, ahead of anticipated Q3 earnings, and continued to slide after the closing bell, ...

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their ...

According to TipRanks, Tenthoff is an analyst with an average return of -9.7% and a 36.01% success rate. Tenthoff covers the Healthcare sector, focusing on stocks such as Arvinas Holding Company, Skye ...